Updated Nov 4, 2026FDA and CMS public dataIndependent · free · not health advice
GxRadar
Drugs/Meloxicam 15 mg tablet
Pain / inflammation

Meloxicam 15 mg tablet

Public data on meloxicam from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.

$0.0184
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-24%
change over five years
peak $0.0330 in 2014-02
26
approved generic applications (ANDAs) on record for Meloxicam
15 with a product still marketed · first 2006
Not listed
in FDA's current shortage list
no matching FDA shortage entries

NADAC per unit, monthly

MELOXICAM 15 MG TABLET
Show as table
MonthNADAC per unit ($)
2013-110.02494
2014-020.03297
2014-050.02697
2014-080.02601
2014-110.02431
2015-020.02660
2015-050.02849
2015-080.02563
2015-110.02383
2016-020.02373
2016-050.02546
2016-080.02296
2016-110.02318
2017-020.02039
2017-050.02078
2017-080.02129
2017-110.02115
2018-020.02065
2018-050.01911
2018-080.01923
2018-110.01818
2019-020.01973
2019-050.01967
2019-080.02158
2019-110.02173
2020-020.02158
2020-050.02246
2020-080.02035
2020-110.01995
2021-020.02144
2021-050.02130
2021-080.02291
2021-110.02418
2022-020.02316
2022-050.02456
2022-080.02370
2022-110.02415
2023-020.02200
2023-050.02296
2023-080.02217
2023-110.02006
2024-020.02132
2024-050.01802
2024-080.01973
2024-110.01908
2025-020.01863
2025-050.02019
2025-080.02021
2025-110.01991
2026-020.01994
2026-050.01920
2026-080.01864
2026-110.01842

Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.

Recall records mentioning meloxicam

openFDA enforcement records, by year reported.

20241
20221
20211
20171
20161
20152
20131
20121

9 records since 2012. A record is one product or lot, not one recall event. Combination products that contain meloxicam are included.

What these numbers mean

NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.

Most recent recall records

Class IITerminated
Meloxicam tablets
Reason category: Labeling or packaging error
FDA recall number D-0190-2024
Class IIITerminated
Bupivacaine and meloxicam
Reason category: Labeling or packaging error
FDA recall number D-1335-2022
Class IITerminated
Meloxicam tablets
Reason category: cGMP deviations
FDA recall number D-0463-2021
Class IIITerminated
Meloxicam product
Reason category: Labeling or packaging error
FDA recall number D-0007-2018
Class IITerminated
Meloxicam product
Reason category: Other
FDA recall number D-1103-2016

Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.

Articles that mention meloxicam

4 GxRadar articles cite or discuss this drug.

Labels & identifiers · Explainer · 6 min

Boxed warnings, FDA's most prominent label warning, explained

What 21 CFR 201.57 requires of a boxed warning, how many prescription labels carry one (about a third, by two counts 14 years apart), and why a generic's box matches the brand's.

Using medicines safely · Explainer · 6 min

Look-alike and sound-alike drug names, and how FDA tries to keep them apart

How FDA screens new drug names with its POCA software, why generic names can resemble each other, how tall man lettering works, and what recall records show about mix-ups.

PRICE INDEX · 2014 = 100
Price histories · Data story · 5 min

The cheapest pills in GxRadar's 47-drug price basket

Seven of the 47 generics we track cost pharmacies under 2 cents a unit in October 2026, led by amlodipine at 1.02 cents. Which drugs sit at the floor, how long they have been there, and what the ranking does not show.

Labels & identifiers · Explainer · 5 min

Medication Guides and patient package inserts

What 21 CFR Part 208 requires, when a pharmacy must hand over a Medication Guide, how patient package inserts differ, and where FDA's one-page replacement proposal stands.